WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer 07 November 2017
FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer 01 November 2017
FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma 20 October 2017
FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 06 October 2017
FDA awards six grants for natural history studies in rare diseases 06 October 2017
FDA improves access to reports of adverse drug reactions 28 September 2017
FDA conducts major global operation to protect consumers from potentially dangerous prescription drugs sold online 26 September 2017
FDA approves first biosimilar for the treatment of cancer 14 September 2017
FDA approves Mylotarg for treatment of acute myeloid leukemia 01 September 2017
FDA approval brings first gene therapy to the United States 30 August 2017
FDA approves first U.S. treatment for Chagas disease 30 August 2017
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia 17 August 2017
FDA to expand public education campaign to focus on prevention of youth e-cigarette use 08 August 2017
FDA approves treatment for chronic graft versus host disease 02 August 2017
FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death 28 July 2017
FDA approves Vosevi for Hepatitis C 19 July 2017
FDA tackles drug competition to improve patient access 27 June 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs 26 June 2017
FDA approves first generic Strattera for the treatment of ADHD 31 May 2017
FDA approves first cancer treatment for any solid tumor with a specific genetic feature 23 May 2017
  • Start
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next
  • End

Business & Industry

  • Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
  • CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma

Research & Development

  • Candidate found to inhibit malignant melanoma growth
  • A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA approves first over-the-counter naloxone nasal spray
  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  1. You are here:  
  2. Home
  3. FDA

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.